{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04458",
    "Peptide Name": "Peptide 3 (Tritrpticin derived, synthetic AMPs, Trp-rich, UCLL1)",
    "Source": "sequence truncation, cathelicidin analog, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "RFPWWWPFLR",
    "Sequence Length": 10,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Rich",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 2,
    "Boman Index": 1.19,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "60%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (76.92%) toTritrpticinW: 30%, F=R=P: 20%.Activity: Zone inhibition assay: Active against E. coli, P. aeruginosa, K. pneumonia, S.epidermidis,  P.mirabilis,  and  Streptococcus  group  D. Poorly active against fungi A.fumigatus (MIC 500 ug/ml) and C.albicans (>1000 ug/ml).",
    "Author": "Lawyer C, Pai S, Watabe M, Borgia P, Mashimo T, Eagleton L, Watabe K. 1996",
    "Reference": "FEBS Lett. 1996 Jul 15;390(1):95-8. doi: 10.1016/0014-5793(96)00637-0.PubMed",
    "Title": "Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides."
  },
  "3D Structure": []
}